MOSES: Procalcitonin Monitoring Sepsis Study
Sponsor
Brahms AG (Industry)
Overall Status
Completed
CT.gov ID
NCT01523717
Collaborator
(none)
858
13
27
66
2.4
Study Details
Study Description
Brief Summary
The purpose of this study is to investigate the relationship between a procalcitonin decrease over 72 hours and outcome in patients who have severe sepsis or septic shock.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
858 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Procalcitonin Decrease Over 72 Hours and Outcome in Patients With Severe Sepsis or Septic Shock
Study Start Date
:
Dec 1, 2011
Actual Primary Completion Date
:
Mar 1, 2014
Actual Study Completion Date
:
Mar 1, 2014
Outcome Measures
Primary Outcome Measures
- 28 day all cause mortality [within 28 day safter inlclusion]
participants will be followed up for 28 days
Secondary Outcome Measures
- all-cause in-hospital mortality [mortality during hospital stay]
count all death through out stay in the hospital
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Adult patients (i.e. >18 years of age) diagnosed with severe sepsis or septic shock as defined in Appendix 1, who are already in the ICU or come from the ED, other wards or directly from out of hospital
-
Blood sample collection within 12 hours after diagnosis "severe sepsis or septic shock"No prior enrollment into this study
-
Written informed consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of California Davis Health System | Sacramento | California | United States | 95817 |
2 | Northwestern University | Chicago | Illinois | United States | 60611 |
3 | Beth Israel Deaconess Medical Center | Boston | Massachusetts | United States | 02215 |
4 | Saint Vincent Hospital | Worcester | Massachusetts | United States | 01608 |
5 | Detroit Receiving Hospital | Detroit | Michigan | United States | 48201 |
6 | Sinai Grace Hospital | Detroit | Michigan | United States | 48201 |
7 | Henry Ford Health System | Detroit | Michigan | United States | 48202 |
8 | University of Mississippi Medical Center | Jackson | Mississippi | United States | 39216 |
9 | New York Methodist Hospital | New York | New York | United States | 11215 |
10 | Stony Brook University | New York | New York | United States | 11794 |
11 | Carolinas Medical Center | Charlotte | North Carolina | United States | 28203 |
12 | Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | United States | 19104 |
13 | Vanderbilt University Medical Center | Nashville | Tennessee | United States | 37232 |
Sponsors and Collaborators
- Brahms AG
Investigators
- Principal Investigator: Nathan Shapiro, MD, Beth Israel Deaconess Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Brahms AG
ClinicalTrials.gov Identifier:
NCT01523717
Other Study ID Numbers:
- brahms-moses
First Posted:
Feb 1, 2012
Last Update Posted:
Mar 17, 2015
Last Verified:
Mar 1, 2015
Keywords provided by Brahms AG
Additional relevant MeSH terms: